OSI Systems (OSIS) Q2 2026 earnings review
Records in Security, Crisis in Healthcare
OSI Systems delivered a mixed but generally positive Q2. Top-line performance was robust with 11% revenue growth to a record $464M, driven by a 15% surge in the Security division. However, the 'beat' was uneven. While Security and Optoelectronics thrived, the Healthcare segment collapsed, shrinking 19% and swinging to a GAAP operating loss. Despite softer-than-expected bookings due to the U.S. government shutdown, management raised full-year EPS guidance, signaling confidence that margin expansion and share buybacks will offset divisional weakness.
🐂 Bull Case
The core growth engine is firing on all cylinders. Security revenue jumped 15% to $335M. Even with difficult year-over-year comparisons, the division maintained a solid backlog, positioning it well for the second half of the fiscal year.
Management is aggressively using capital. They raised $575M via convertible notes and immediately deployed $146M into share repurchases, reducing the share count and supporting the EPS raise.
🐻 Bear Case
Healthcare is a major drag. Revenue fell 19% YoY to $36.5M, and the segment swung from a $1.7M GAAP profit last year to a $1.1M loss this quarter. The turnaround story here is failing to materialize.
Management explicitly noted bookings were 'softer than expected,' blaming the U.S. government shutdown. While backlog remains flat at $1.8B, an inability to convert pipeline to firm orders in Q3 would jeopardize the growth narrative.
⚖️ Verdict: 🟢
Bullish. The 11% revenue growth and EPS guidance raise outweigh the Healthcare implosion. The core Security business is robust enough to carry the company, but the bookings slowdown requires close monitoring.
Key Themes
Security Division Dominance
Security remains the undeniable leader, generating 72% of total revenue. Sales grew 15% YoY to $335M. While margins compressed slightly (Non-GAAP operating margin dropped from 19.9% to 17.8%), the absolute profit dollars grew. The expansion of recurring services revenue is a key stabilizer against hardware lumpiness.
Healthcare Profitability Erasure
The Healthcare division is in freefall. Revenue dropped from $44.9M to $36.5M (-19%). More alarmingly, operational leverage kicked in reverse: GAAP operating income fell from a $1.7M profit in 25Q2 to a $1.1M loss in 26Q2. Non-GAAP margins evaporated from 4.7% to 1.5%. Management cites 'strategic initiatives,' but the numbers suggest lost market share or delayed orders.
Government Shutdown Impact on Bookings
Bookings were 'softer than expected' due to the U.S. government shutdown delaying anticipated orders. While the backlog remained stable at $1.8B (flat vs June 2025), a prolonged delay in government awards could create an air pocket in future revenue recognition. This contradicts the 'strong momentum' narrative in the Security division.
Optoelectronics Vertical Integration
The Optoelectronics & Manufacturing segment grew 12% YoY to $112.6M, with Non-GAAP margins holding steady at ~12.9%. Management highlighted the 'vertically-integrated global structure' as a competitive moat. This segment provides a stable, double-digit growth counterbalance to the volatility of Security contracts.
Aggressive Capital Restructuring
OSI issued $575M in convertible notes and repurchased $146M of stock. This move lowers the cost of capital (0.50% interest rate on notes) and reduces the share count, directly boosting EPS. The GAAP diluted share count rose slightly (17.47M vs 17.04M) likely due to dilution effects, but the buyback mitigates this.
Other KPIs
Stable. Up 18% from $52.5M in the prior year. The company is generating healthy cash despite the earnings drag from Healthcare, supporting the buyback capability.
Decelerating. Down from 19.9% in the prior year period. Management noted margins were lower due to a 'difficult year-over-year comparison,' likely implying a mix shift toward lower-margin hardware or fewer high-margin 'Mexico contract' contributions compared to last year.
Guidance
Accelerating. Raised from prior guidance. The new range implies 10-13% YoY growth. This is a bullish signal that cost controls and share buybacks are expected to outweigh the Healthcare operational weakness.
Stable. Management maintained previous revenue guidance (implied from Q1 raise). This suggests they expect the softness in bookings to be temporary and recovered within the fiscal year.
Key Questions
Healthcare Turnaround Visibility
Healthcare revenue collapsed 19% and margins turned negative. Is this a one-quarter inventory correction by customers, or a structural loss of market share? When do you expect this segment to return to profitability?
Security Margin Compression
Security margins contracted 210 basis points YoY (19.9% to 17.8%) despite 15% revenue growth. Was this driven by pricing pressure, mix shift to lower-margin hardware, or the roll-off of high-margin legacy contracts?
Government Shutdown & Bookings
You mentioned bookings were softer than expected due to the shutdown. Have you seen these delayed orders materialize in January, or is the risk of further delays persisting into Q3?
Optoelectronics Demand Durability
Opto grew 12% YoY. Are you seeing any changes in OEM ordering patterns given the broader macro uncertainty, or is this demand fully backed by firm long-term agreements?